Matthew Makin - Honorary Professor Health and Behavioural Sciences

Prof Matthew Makin
Name
Prof Matthew Makin
Position
Honorary Professor Health and Behavioural Sciences
Email
matthew.makin@pat.nhs.uk
Phone
0161 604 5468
Location
College of Human Sciences

Biography

Prof Makin was appointed as Medical Director of The Penine Acute Hospitals NHS Trust in March 2016 and previously was the Executive Medical Director Betsi Cadwaladr University Health Board (BCUHB) between 2014 and 2016. He has a clinical background in Oncology, General Medicine, Palliative Medicine and General Practice, with academic interests into the cause and treatment of Cancer Pain, Cancer and Primary Care and Clinical Ethics in Medicine. As a Consultant in Palliative Care Medicine, he has worked across community and hospital settings and from 2009 -2013 was the Chief of Staff for the Cancer Clinical Programme Group at BCUHB.

Prof. Makin was the founding Chair of the North Wales Neuroscience Network and up until recently the Programme Lead for Pain Research at the Marie Curie Palliative Care Institute in Liverpool. From 2001 to 2009 he was the Medical Director of Nightingale House Hospice, and he established the North Wales Department of Palliative Care Medicine. His research has led to the internationally recognised Morley-Makin approach for Cancer Pain Management and he leads the National Registry for Invasive Neurodestructive Procedures in Cancer Pain (INPIC).

He has extensive experience of working at National and Welsh Government level in the field of cancer service improvement and strong relationships with cross border partners and the third sector. A major stream of his work here has been improving the earlier diagnosis of cancer and he has worked with Cancer Research (UK) and organised two national events. He is currently working with Bangor University and BCUHB to develop a distinctive academic profile for Integrated Health Sciences in North Wales.

A member of the National Cancer Research Institute (NCRI) Pain Studies Group, Prof. Makin was awarded an NCRI Lung Cancer Supportive and Palliative Care Award in 2008. £125,000 (Chief Investigator INPIC study).

Recent Funding

  • “Diagnose Quickly Follow up Safely” Bangor University/BCUHB partnership with North Wales Centre for Primary Care Research 2012-2014 £242,000 (Co-applicant)
  • Cancer Research UK Diagnosis Earlier Looking at Your Symptoms – development and evaluation of a patient-centered tool to measure diagnostic delays (Delays 2) 2007–2009 £44,000. (Collaborator).
  • Macmillan Cancer Support: TOPCAT-P: Re-design for follow up of prostate cancer pilot, North Wales. 2013-2015 £297,000 (Co-applicant)

Recent Publications

  • Makin MK. Pharmacological Management of Cancer Pain in: Complex Cancer Pain (Editor Manohar Sharma) 2014 Oxford University Press; Oxford
  • Makin MK. Upper G.I. Cancer Pain in: Complex Cancer Pain (Editor Manohar Sharma) 2014 Oxford University Press; Oxford
  • Makin MK., J. Ellershaw, A. Leach, M. Poolman, M. Sharma, G. Jeffers and J. Bridson The results of the invasive neurodestructive procedures in cancer pain pilot study (INPIC) What is the role of cordotomy in pain associated with malignant mesothelioma? BMJ Support Palliat Care 2012;2:1 doi:10.1136/bmjspcare-2012-000264.2
  • Makin MK. The Invasive Neurodestructive Procedures in Cancer Pain Pilot Study. Pain News March (2012) 10 (1) p39-41
  • Philp MR, Poolman M, Martin NP, Makin MK Opioids in the last days of life: What is good practice? – European Journal of Palliative Care (2009) 16 (3) p110-115
  • Neal RD, Pasterfield D, Wilkinson C, Hood K, Makin MK, Lawrence H. Determining patient and primary care delay in the diagnosis of cancer – lessons from a pilot study of patients referred for suspected cancer. BMC Fam Pract. 30;9: (January 2008)
  • Makin MK. Methadone in: Opioids in Cancer Pain (Editor Karen Forbes) 2007 Oxford University Press; Oxford
  • Morley JS, Bridson J, Nash TP, Miles JB, White S, Makin MK. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind